^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PANAMutyper™ ROS1

    Company:
    Panagene
    Type:
    FDA Approved
    Related tests:

    Details

    Evidence
    News
    HLB Panajin announced that the independently developed diagnostic product 'PANAMutyper ROS1 (PANAMutyper™ ROS1)' has been approved by the Ministry of Food and Drug Safety as a companion diagnostic product of Pfizer's lung cancer targeted treatment 'Zenkori (ingredent name: Crzotinib)'. It is significant in that it was the first domestic company to obtain a companion diagnosis medical device permit for ROS1 biomarker.
    Cancer:
    Lung Cancer
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    02/05/25
    LC
    -
    FDA